T-cell lymphoma in HIV-infected patients

Journal of Acquired Immune Deficiency Syndromes

Volumn 36, Issue 5, 2004, Pages 1020-1027

  Arzoo, Karo K ^a   Bu, Xiangdong ^a   Espina, Byron M ^a   Seneviratne, Lasika ^a   Nathwani, Bharat ^a   Levine, Alexandra M ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

AIDS related lymphoma; T cell lymphoma

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FOLINIC ACID; METHOTREXATE; METHYLPREDNISOLONE; MITOGUAZONE; MYOCEL; PREDNISONE; PROCARBAZINE; VINCAMINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANGIOIMMUNOBLASTIC LYMPHADENOPATHY; ARTICLE; B CELL LYMPHOMA; BONE MARROW; CANCER REGISTRY; CANCER SURVIVAL; DISEASE ASSOCIATION; ENTEROPATHY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; LARGE CELL LYMPHOMA; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; SKIN; T CELL LYMPHOMA;

ADULT; AGED; ANTIGENS, CD; CALIFORNIA; FEMALE; HUMANS; LYMPHOMA, AIDS-RELATED; LYMPHOMA, B-CELL; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; PHENOTYPE; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 3342957049     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200408150-00004     Document Type: Article

References (38)

1. Centers for Disease Control. Revision of the case definition of acquired immunodeficiency syndrome for national reporting-United States. Ann Intern Med. 1985;103:402-403.
2. Biggar RJ. The epidemiology of malignancies in HIV/AIDS. In: Fiegel EG, Levine AM, Biggar RJ, eds. AIDS-Related Cancers and Their Treatment. New York: Marcel Dekker; 2000;25-28.
3. Ledergerber B, Telenti A, Egger M. Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: prospective cohort study. BMJ. 1999;319:23-24.
4. International Collaboration on HIV and Cancer. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Can Inst. 2000;92:1823-1830.
5. Mocroft A, Katlama C, Johnson AM, et al. AIDS across Europe, 1994-98: the EuroSIDA study. Lancet. 2000;356:291-296.
6. Levine AM. Acquired immunodeficiency syndrome-related lymphoma. Blood. 1992;80:8-20.
7. Cote TR, Biggar RF, Rosenberg PS, et al. Non-Hodgkin's lymphoma among people with AIDS. Incidence, presentation, and public health burden. Int J Cancer. 1997;73:654-660.
8. Levine AM, Seneviratne L, Espina BM, et al. Evolving characteristics of AIDS-related lymphoma. Blood. 2000;96:4084-4090.
9. Gaidano G, Pastore C, Gloghino A, et al. AIDS-related non-Hodgkin's lymphoma: molecular, genetic, viral infection and cytokine deregulation. Acta Haematol. 1996;95:193-198.
10. Pelicci P-G, Knowles DM, Arlin ZA, et al. Multiple monoclonal B-cell expansions and c-myc oncogene rearrangements in acquired immune deficiency syndrome-related lymphoproliferative disorders-implications for lymphomagenesis. J Exp Med. 1986;164:2049-2076.
11. Arber DA, Chang KL, Weiss LM. Peripheral T-cell lymphoma with Touton-like tumor giant cells associated with HIV infection: report of two cases. Am J Surg Pathol. 1999;23:519-522.
12. Jhala DN, Medeiros LJ, Lopez-Terrada D, et al. Neutrophil-rich anaplastic large cell lymphoma of T-cell lineage. A report of two cases arising in HIV-positive patients. Am J Clin Pathol. 2000;114:478-482.
13. Gonzalez-Clemente JM, Ribera JM, Campo E, et al. Ki-1+ anaplastic large-cell lymphoma of T-cell origin in an HIV-infected patient. AIDS. 1991;5:751-755.
14. Nasr SA, Brynes RK, Garrison CP, et al. Peripheral T-cell lymphomas in a patient with acquired immunodeficiency syndrome. Cancer. 1988;61: 947-951.
15. Sternlieb J, Mintzer D, Kwa D, et al. Peripheral T-cell lymphomas in a patient with the acquired immunodeficiency syndrome. Am J Med. 1988; 85:445.
16. Janer M, Katlama C, Flageul B, et al. The pseudo-Sézary syndrome with CD8 phenotype in a patient with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med. 1989;110:738-740.
17. Lum G, Cosgriff T, Byrne R, et al. Primary T-cell lymphoma of muscle in a patient infected with human immunodeficiency virus. Am J Med. 1993;95:545-546.
18. Herndier BG, Shiramizu BT, Jewett NE, et al. Acquired immunodeficiency syndrome-associated T-cell lymphoma: evidence for human immunodeficiency virus type 1-associated T-cell transformation. Blood. 1992;7: 1768-1774.
19. Kohler CA, Gonzalez-Ayala E, Rowley P, et al. Primary pulmonary T-cell lymphoma associated with AIDS: the syndrome of the indolent pulmonary mass lesion. Am J Med. 1995;99:324-326.
20. Biggar RJ, Engels EA, Frish M, et al. Risk of T-cell lymphoma in persons with AIDS. J Acquired Immune Defic Syndr. 2000;26:371-376.
21. Harris NL, Jaffe ES, Diebold J, et al. The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting Airlie House, Virginia, November 1997. J Clin Oncol. 1999;17:3835-3849.
22. Mehta CR, Patel NR. A network algorithm for performing Fisher's exact test in r × c contingency tables. J Am Stat Assoc. 1983;78:427-434.
23. Kalbfliesch JD, Prentice RI. The Statistical Analysis of Failure Time Data. New York: John Wiley and Sons; 1980.
24. Tarone RE, Ware J. On distribution-free tests for equality of survival distributions. Biometrika. 1997;6:156.
25. Ratner L, Lee J, Tang S, et al. Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy. J Clin Oncol. 2001;19:2171-2178.
26. Levine AM, Wernz JC, Kaplan L, et al. Low dose chemotherapy with central nervous system prophylaxis and azidothymidine maintenance in AIDS-related lymphoma: a prospective multi-institutional trial. JAMA. 1991;266:84-88.
27. Velasquez WS, McLaughlin P, Tucker S, et al. ESHAP-an effective chemotherapy regimen in refractory and relapsed lymphoma: a 4-year follow-up study. J Clin Oncol. 1994;12:1169-1176.
28. Gisselbrecht C, Gaulard P, Lepage E, et al. Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Group d'Etudes des lymphomas de l'Adulte (GELA). Blood. 1998;92:76-82.
29. Lopez-Guillermo A, Cid J, Salar A, et al. Peripheral T-cell lymphomas: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. classification. Ann Oncol. 1998;9:849-855.
30. Brugieres L, Deley MC, Pacquement H, et al. CD30(+) anaplastic large-cell lymphoma in children: analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric Oncology. Blood. 1998;92:3591-3598.
31. Bunn PA, Schechter GP, Jaffe E, et al. Clinical course of retrovirus-associated adult T-cell lymphoma in United States. N Engl J Med. 1983; 309:257-264.
32. Lippman SM, Miller TP, Spier CM. The prognostic significance of the immunotype in diffuse large-cell lymphoma: a comparative study of the T-cell and B-cell phenotype. Blood. 1988;72:436-441.
33. The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood. 1997;89:3909-3918.
34. Levine AM, Sullivan-Halley J, Gill PS, et al. HIV-related lymphoma: prognostic factors predictive of survival. Cancer. 1991;68:2466-2472.
35. Straus DJ, Huang J, Testa MA, et al. Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: analysis of AIDS Clinical Trials Groups protocol 142: low dose versus standard dose m-BACOD plus granulocyte-macrophage colony-stimulating factor. J Clin Oncol. 1998;16:3601-3606.
36. Tirelli U, Vaccher E, Zagonel V, et al. CD30 (Ki-1) positive anaplastic large-cell lymphomas in 13 patients with and 27 patients without human deficiency virus infection: the first comparative clinicopathologic study from a single institution that also includes 80 patients with other human immunodeficiency virus-related systemic lymphomas. J Clin Oncol. 1995;13:373-380.
37. Nosari A, Cantoni S, Oreste P, et al. Anaplastic large cell (CD30/Ki-1+) lymphoma in HIV+ patients: clinical and pathologic findings in a group of ten patients. Br J Haematol. 1996;95:508-512.
38. Chadburn A, Cesarman E, Jagirdar J, et al. CD30 (Ki-1) positive anaplastic large cell lymphomas in individuals infected with the human immunodeficiency virus. Cancer. 1993;72:3078-3090.